Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Ophthalmology · Thyroid Eye Disease

Recognizing Symptoms and Red Flags of TED

At a Glance

Thyroid Eye Disease (TED) symptoms progress from surface irritation and dry eye to structural changes like bulging eyes and double vision. Sudden color vision changes, dimming vision, or constant blurriness are medical emergencies indicating optic nerve compression that require immediate treatment.

Understanding the symptoms of Thyroid Eye Disease (TED) is not just about managing discomfort; it is about knowing when your vision is in danger. TED symptoms typically follow a progression, but they can vary significantly from person to person [1]. By learning to distinguish between common irritation and “red flag” emergencies, you can take a proactive role in protecting your sight.

Early Symptoms: The Inflammatory Phase

In the early stages, TED often presents as surface irritation. This is frequently caused by evaporative dry eye, which happens when your eyelids don’t close completely or blink effectively, allowing the eye’s natural moisture to evaporate too quickly [2][3].

  • Grittiness: A feeling like there is sand or a foreign object in your eye [4].
  • Watering and Tearing: Your eyes may overproduce tears as a reflex to the dryness [2].
  • Photophobia: A new or increased sensitivity to bright lights [5].
  • Puffiness: Swelling of the eyelids or the white part of the eye (known as chemosis) [1].

Day-to-Day Coping Strategies

While waiting for medical treatments to take effect, you can manage daily discomfort by:

  • Using thick, preservative-free lubricating drops or gels throughout the day.
  • Taping your eyelids shut at night with medical tape, or wearing moisture-chamber sleep goggles to prevent the cornea from drying out [6].
  • Wearing wrap-around sunglasses outdoors to block wind and bright light.

Progressive Symptoms: Structural Changes

As the disease progresses, the tissues behind the eye (muscles and fat) can expand, leading to more visible changes in your appearance and how your eyes move [7].

  • Eyelid Retraction: Your upper or lower lids may pull back, exposing more of the white of the eye and creating a “staring” look. This is often caused by inflammation in the muscles that lift the eyelids [8].
  • Proptosis (Bulging Eyes): Because the eye socket is made of bone and cannot expand, the swelling of the tissues behind the eye pushes the eyeball forward [9][10].
  • Diplopia (Double Vision): When the muscles that move the eye become swollen or stiff (fibrosis), the eyes may stop working together in perfect alignment. This results in seeing two of everything [11][12].
    • Tip for double vision: Your doctor may prescribe prism glasses, which bend the light entering your eye to help align the two images into one while you wait for your disease to stabilize [13].

Medical Emergency: Dysthyroid Optic Neuropathy (DON)

The most serious complication of TED is Dysthyroid Optic Neuropathy (DON). This occurs when the swollen muscles at the very back of the eye socket become so large that they “squeeze” or compress the optic nerve, which is the vital cable that sends visual information to your brain [14][15]. This is a medical emergency that requires immediate treatment (such as high-dose IV steroids or urgent surgery) to prevent permanent vision loss [16].

Red Flags of Optic Nerve Compression:

If you experience any of the following, contact your eye specialist immediately or go to an emergency room:

  • Color Vision Changes (Dyschromatopsia): Colors, especially reds and blues, may suddenly look “washed out,” “gray,” or less vibrant in one eye [17][18].
  • Dimming of Vision: A sense that the lights have been turned down, or that you are looking through a gray “haze” or “film” that does not go away when you blink [19].
  • Loss of Visual Field: Noticing “holes” or dark spots in your vision, particularly in your central or lower field of view [19][15].
  • Constant Blurriness: Blurred vision that is not relieved by eye drops or blinking [20].

Communicate these symptoms clearly to your doctor. Mentioning “color changes” or “dimming vision” specifically will signal to your care team that you need an urgent evaluation for potential nerve compression [16].

Common questions in this guide

What are the earliest signs of Thyroid Eye Disease?
Early signs of TED usually involve surface irritation caused by evaporative dry eye. You may experience a gritty feeling, excessive watering, sensitivity to bright lights, and puffiness around the eyes.
How can I manage the dry eye and irritation from TED?
You can use thick, preservative-free lubricating drops or gels throughout the day to soothe your eyes. At night, wearing moisture-chamber sleep goggles or taping your eyelids shut can prevent them from drying out while you sleep.
Why does Thyroid Eye Disease cause double vision?
TED causes inflammation and swelling in the muscles that move your eyes. When these muscles become stiff or swollen, your eyes can no longer align perfectly, resulting in double vision.
What is Dysthyroid Optic Neuropathy (DON)?
DON is a serious medical emergency where swollen muscles and fat in the eye socket squeeze the optic nerve. This compression can lead to permanent vision loss if not treated immediately with strong steroids or surgery.
What vision changes are red flags for optic nerve compression?
Immediate red flags include colors looking washed out or gray, a dimming or hazy film over your vision, dark spots in your visual field, and constant blurriness that does not improve when you blink. If you experience these, contact an eye specialist or go to the emergency room immediately.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current examination, do you see any signs of optic nerve compression or Dysthyroid Optic Neuropathy (DON)?
  2. 2.Is the double vision I'm experiencing due to active inflammation or permanent muscle scarring (fibrosis)?
  3. 3.If I notice a sudden change in how I see colors, especially red or blue, what is the fastest way to reach your team after hours?
  4. 4.Would you recommend a prescription for specialized prism glasses to help manage my double vision while we wait for the active phase to end?
  5. 5.Are the dry-eye symptoms I have typical for TED, or do they indicate I'm not closing my eyes fully at night (lagophthalmos)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Carotid-Cavernous Sinus Fistula Masquerading as Thyroid Eye Disease.

    Azzam DB, Cypen SG, Conger JR, Tao JP

    Cureus 2021; (13(4)):e14261 doi:10.7759/cureus.14261.

    PMID: 33959444
  2. 2

    Ocular Surface Changes in Treatment-Naive Thyroid Eye Disease.

    Liao X, Lai KKH, Aljufairi FMAA, et al.

    Journal of clinical medicine 2023; (12(9)) doi:10.3390/jcm12093066.

    PMID: 37176507
  3. 3

    Functional and structural evaluation of the meibomian gland using a LipiView interferometer in thyroid eye disease.

    Park J, Kim J, Lee H, et al.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(4)):373-379 doi:10.1016/j.jcjo.2017.11.006.

    PMID: 30119792
  4. 4

    Corneal Mechanical Thresholds Negatively Associate With Dry Eye and Ocular Pain Symptoms.

    Spierer O, Felix ER, McClellan AL, et al.

    Investigative ophthalmology & visual science 2016; (57(2)):617-25 doi:10.1167/iovs.15-18133.

    PMID: 26886896
  5. 5

    Quantification of Conjunctival Dendritiform Cells under In Vivo Confocal Microscopy for Clinical Activity Evaluation in Thyroid Eye Disease.

    Cai J, Zheng T, Ng TK, et al.

    Current eye research 2025; (50(10)):1003-1009 doi:10.1080/02713683.2025.2521865.

    PMID: 40556308
  6. 6

    Efficacy of Simple Eye Ointment, Polyethylene Cover, and Eyelid Taping in Prevention of Ocular Surface Disorders in Critically Ill Patients: A Randomized Clinical Trial.

    Ahmadinejad M, Karbasi E, Jahani Y, et al.

    Critical care research and practice 2020; (2020()):6267432 doi:10.1155/2020/6267432.

    PMID: 32351735
  7. 7

    Advancing the Therapeutic Frontier in Thyroid Eye Disease.

    Mohammadi SO, Ray C

    TouchREVIEWS in endocrinology 2025; (21(2)):12-14 doi:10.17925/EE.2025.21.2.2.

    PMID: 41246121
  8. 8

    Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction.

    Joos ZP, Sullivan TJ

    Clinical & experimental ophthalmology 2017; (45(6)):651-652 doi:10.1111/ceo.12939.

    PMID: 28248444
  9. 9

    Interleukin-27 is a multitarget regulator of fibroblast remodeling in thyroid-associated ophthalmopathy.

    Zhang P, Wang X, Lu N, et al.

    iScience 2025; (28(12)):113982 doi:10.1016/j.isci.2025.113982.

    PMID: 41362621
  10. 10

    A Review of Novel Medical Treatments for Thyroid Eye Disease.

    Park JW, Yoon JS

    Korean journal of ophthalmology : KJO 2024; (38(3)):249-259 doi:10.3341/kjo.2024.0031.

    PMID: 38773958
  11. 11

    Clinical profiles of thyroid eye disease with and without strabismus: a comparative study.

    Khorrami-Nejad M, Akbari MR, Azizi E, et al.

    International journal of ophthalmology 2025; (18(12)):2366-2371 doi:10.18240/ijo.2025.12.19.

    PMID: 41280616
  12. 12

    Management of Thyroid Eye Disease-Related Strabismus.

    Akbari MR, Mirmohammadsadeghi A, Mahmoudzadeh R, Veisi A

    Journal of current ophthalmology 2020; (32(1)):1-13 doi:10.1016/j.joco.2019.10.002.

    PMID: 32510007
  13. 13

    The effect of previous orbital decompression on outcomes of rectus muscle recession surgery in patients with thyroid ophthalmopathy.

    Hou X, Tu Y, Min X, et al.

    Journal francais d'ophtalmologie 2024; (47(1)):103924 doi:10.1016/j.jfo.2023.01.045.

    PMID: 37775455
  14. 14

    Dysthyroid optic neuropathy: Demographics, risk factors, investigations, and management outcomes.

    Poonam NS, Alam MS, Oberoi P, Mukherjee B

    Indian journal of ophthalmology 2022; (70(12)):4419-4426 doi:10.4103/ijo.IJO_719_22.

    PMID: 36453357
  15. 15

    Predominant Contribution of Superior Rectus-Levator Complex Enlargement to Optic Neuropathy and Inferior Visual Field Defects in Thyroid Eye Disease.

    Oropesa S, Dunbar KE, Godfrey KJ, et al.

    Ophthalmic plastic and reconstructive surgery 2019; (35(3)):262-265 doi:10.1097/IOP.0000000000001224.

    PMID: 30124604
  16. 16

    Dysthyroid Optic Neuropathy.

    Potvin ARGG, Pakdel F, Saeed P

    Ophthalmic plastic and reconstructive surgery 2023; (39(6S)):S65-S80 doi:10.1097/IOP.0000000000002555.

    PMID: 38054987
  17. 17

    A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.

    Garip Kuebler A, Halfter K, Reznicek L, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2021; (259(11)):3421-3426 doi:10.1007/s00417-021-05227-8.

    PMID: 34159407
  18. 18

    Analysis of colour defects and microvascular abnormalities in dysthyroid optic neuropathy using optical coherence tomography angiography.

    Liang J, Fan S, Zhou C, et al.

    Photodiagnosis and photodynamic therapy 2025; (56()):105287 doi:10.1016/j.pdpdt.2025.105287.

    PMID: 41270920
  19. 19

    Reduced choroidal peripapillary capillaries in thyroid-associated ophthalmopathy with early stage of dysthyroid optic neuropathy.

    Wu JH, Luo LY, Zhou H, et al.

    International journal of ophthalmology 2022; (15(7)):1135-1141 doi:10.18240/ijo.2022.07.14.

    PMID: 35919331
  20. 20

    Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.

    Stoyanova NS, Konareva-Kostianeva MI, Mitkova-Hristova VT

    Folia medica 2020; (62(2)):418-423 doi:10.3897/folmed.62.e47689.

    PMID: 32666771

This page provides information on the symptoms and red flags of Thyroid Eye Disease for educational purposes. It does not replace professional medical advice, and you should seek immediate emergency care if you experience sudden vision changes.

Get notified when new evidence is published on thyrotoxic exophthalmos.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.